Crossref journal-article
Springer Science and Business Media LLC
Leukemia (297)
Bibliography

Schoch, C., Schnittger, S., Bursch, S., Gerstner, D., Hochhaus, A., Berger, U., Hehlmann, R., Hiddemann, W., & Haferlach, T. (2002). Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia, 16(1), 53–59.

Authors 9
  1. C Schoch (first)
  2. S Schnittger (additional)
  3. S Bursch (additional)
  4. D Gerstner (additional)
  5. A Hochhaus (additional)
  6. U Berger (additional)
  7. R Hehlmann (additional)
  8. W Hiddemann (additional)
  9. T Haferlach (additional)
References 28 Referenced 229
  1. Rowley JD . A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining Nature 1973 243: 290–293 (10.1038/243290a0) / Nature by JD Rowley (1973)
  2. Davis RL, Konopka JB, Witte ON . Activation of the c-abl oncogene by viral transduction generates altered c-abl proteins with similar in vitro kinase properties Mol Cell Biol 1985 5: 204–213 (10.1128/MCB.5.1.204) / Mol Cell Biol by RL Davis (1985)
  3. Daley GQ, Van Etten RA, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome Science 1990 247: 824–830 (10.1126/science.2406902) / Science by GQ Daley (1990)
  4. Ganesan TS, Rassool R, Guo A-P, Th'ng KH, Dowding C, Hibbin JA, Young BD, White H, Kumaran TO, Galton DAG, Goldman JM . Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia Blood 1986 68: 957–960 (10.1182/blood.V68.4.957.957) / Blood by TS Ganesan (1986)
  5. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D . Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization Science 1990 250: 559–562 (10.1126/science.2237408) / Science by DC Tkachuk (1990)
  6. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP . Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro Proc Natl Acad Sci USA 1988 85: 5698–5702 (10.1073/pnas.85.15.5698) / Proc Natl Acad Sci USA by ES Kawasaki (1988)
  7. Reiter A, Skladny H, Hochhaus A, Seifarth W, Heimpel H, Bartram CR, Cross NCP, Hehlmann R . Molecular response of CML patients treated with interferon-a monitored by quantitative Southern blot analysis Br J Haematol 1997 97: 86–93 (10.1046/j.1365-2141.1997.32645.x) / Br J Haematol by A Reiter (1997)
  8. Hochhaus A, Weisser A, La Rosée P, Emig M, Müller MC, Saussele S, Reiter A, Kuhn C, Berger U, Hehlmann R, Cross NCP . Detection and quantification of residual disease in chronic myelogenous leukemia Leukemia 2000 14: 998–1005 (10.1038/sj.leu.2401811) / Leukemia by A Hochhaus (2000)
  9. Nanjangud G, Kadam PR, Saikia T, Bhisey AN, Kumar A, Gopal R, Chopra H, Nair CN, Advani SH . Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisis Leuk Res 1994 18: 385–392 (10.1016/0145-2126(94)90023-X) / Leuk Res by G Nanjangud (1994)
  10. Mitelman F . The cytogenetic scenario of chronic myeloid leukemia Leuk Lymphoma 1993 11: 11–15 (10.3109/10428199309047856) / Leuk Lymphoma by F Mitelman (1993)
  11. Cross NC . Minimal residual disease in chronic myeloid leukaemia Hematol Cell Ther 1998 40: 224–228 / Hematol Cell Ther by NC Cross (1998)
  12. Seong DC, Kantarjian HM, Ro JY, Talpaz M, Xu J, Robinson JR, Deisseroth AB, Champlin RE, Siciliano MJ . Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment Blood 1995 86: 2343–2349 (10.1182/blood.V86.6.2343.bloodjournal8662343) / Blood by DC Seong (1995)
  13. Lion T, Izraeli S, Henn T, Gaiger A, Mor W, Gadner H . Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction Leukemia 1992 6: 495–499 / Leukemia by T Lion (1992)
  14. Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A, Berger U, Hehlmann R, Cross NC, Hochhaus A . Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR Leukemia 1999 13: 1825–1832 (10.1038/sj.leu.2401566) / Leukemia by M Emig (1999)
  15. Preudhomme C, Revillion F, Merlat A, Hornez L, Roumier C, Duflos Grardel N, Jouet JP, Cosson A, Peyrat JP, Fenaux P . Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a ‘real time’ quantitative RT-PCR assay Leukemia 1999 13: 957–964 (10.1038/sj.leu.2401426) / Leukemia by C Preudhomme (1999)
  16. Fonatsch C, Schaadt M, Kirchner H, Diehl V . A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines Int J Cancer 1980 26: 749–756 (10.1002/ijc.2910260608) / Int J Cancer by C Fonatsch (1980)
  17. ISCN 1995 In: Mitelman F (ed.). Guidelines for Cancer Cytogenetics, Supplement to: An International System for HumanCytogenetic Nomenclature S Karger: Basel 1995
  18. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M . Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service Ann Intern Med 1995 122: 254–261 (10.7326/0003-4819-122-4-199502150-00003) / Ann Intern Med by HM Kantarjian (1995)
  19. Maurer J, Janssen JWG, Thiel E, van Denderen J, Ludwig W-D, Aydemir Ü, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR . Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by polymerase chain reaction Lancet 1991 337: 1055–1058 (10.1016/0140-6736(91)91706-Z) / Lancet by J Maurer (1991)
  20. Seong CM, Giralt S, Kantarjian H, Xu J, Swantkowski J, Hayes K, Glassman AB, Khouri I, Korbling M, Thall P, Siciliano MJ, Champlin RE . Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia J Clin Oncol 2000 18: 1831–1836 (10.1200/JCO.2000.18.9.1831) / J Clin Oncol by CM Seong (2000)
  21. Wilkens L, Varga S, Werner M, Nolte M, v Wasielewski R, Georgii A . Short-term culturing influences the number of bcr/abl-fused cells detected by fluorescence in situ hybridisation in bone marrow aspirates of CML patients Pathobiology 1999 67: 163–168 (10.1159/000028067) / Pathobiology by L Wilkens (1999)
  22. Cuneo A, Bigoni R, Emmanuel B, Smit E, Rigolin GM, Roberti MG, Bardi A, Piva N, Scapoli G, Castoldi G, Van Den Berghe H, Hagemeijer A . Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis Leukemia 1998 12: 1718–1723 (10.1038/sj.leu.2401163) / Leukemia by A Cuneo (1998)
  23. Buno I, Wyatt WA, Zinsmeister AR, Dietz Band J, Silver RT, Dewald GW . A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia Blood 1998 92: 2315–2321 (10.1182/blood.V92.7.2315) / Blood by I Buno (1998)
  24. Muhlmann J, Thaler J, Hilbe W, Bechter O, Erdel M, Utermann G, Duba HC . Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment Genes Chromosomes Cancer 1998 21: 90–100 (10.1002/(SICI)1098-2264(199802)21:2<90::AID-GCC3>3.0.CO;2-2) / Genes Chromosomes Cancer by J Muhlmann (1998)
  25. Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, Harousseau JL, Bataille R, Avet Loiseau H . Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia J Clin Oncol 2000 18: 1533–1538 (10.1200/JCO.2000.18.7.1533) / J Clin Oncol by S Le Gouill (2000)
  26. Sinclair PB, Green AR, Grace C, Nacheva EP . Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridization system Blood 1997 90: 1395–1402 (10.1182/blood.V90.4.1395) / Blood by PB Sinclair (1997)
  27. Dewald GW, Wyatt WA, Juneau AL, Carlson RO, Zinsmeister AR, Jalal SM, Spurbeck JL, Silver RT . Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia Blood 1998 91: 3357–3365 (10.1182/blood.V91.9.3357) / Blood by GW Dewald (1998)
  28. Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P . Polymerase chain-reaction detection for the bcr-abl fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implication in 346 patients Blood 1995 85: 2632–2640 (10.1182/blood.V85.9.2632.bloodjournal8592632) / Blood by JP Radich (1995)
Dates
Type When
Created 22 years, 11 months ago (Sept. 5, 2002, 2:45 p.m.)
Deposited 3 years, 5 months ago (March 31, 2022, 5:53 p.m.)
Indexed 5 days, 23 hours ago (Aug. 29, 2025, 6:44 a.m.)
Issued 23 years, 8 months ago (Jan. 1, 2002)
Published 23 years, 8 months ago (Jan. 1, 2002)
Published Online 23 years, 7 months ago (Jan. 24, 2002)
Published Print 23 years, 8 months ago (Jan. 1, 2002)
Funders 0

None

@article{Schoch_2002, title={Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases}, volume={16}, ISSN={1476-5551}, url={http://dx.doi.org/10.1038/sj.leu.2402329}, DOI={10.1038/sj.leu.2402329}, number={1}, journal={Leukemia}, publisher={Springer Science and Business Media LLC}, author={Schoch, C and Schnittger, S and Bursch, S and Gerstner, D and Hochhaus, A and Berger, U and Hehlmann, R and Hiddemann, W and Haferlach, T}, year={2002}, month=jan, pages={53–59} }